AU5453300A - Insulin crystals for pulmonary administration - Google Patents

Insulin crystals for pulmonary administration

Info

Publication number
AU5453300A
AU5453300A AU54533/00A AU5453300A AU5453300A AU 5453300 A AU5453300 A AU 5453300A AU 54533/00 A AU54533/00 A AU 54533/00A AU 5453300 A AU5453300 A AU 5453300A AU 5453300 A AU5453300 A AU 5453300A
Authority
AU
Australia
Prior art keywords
pulmonary administration
insulin crystals
insulin
crystals
pulmonary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54533/00A
Inventor
Michael Rosario De Felippis
Michael Allen Dobbins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU5453300A publication Critical patent/AU5453300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU54533/00A 1999-06-29 2000-06-12 Insulin crystals for pulmonary administration Abandoned AU5453300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14143099P 1999-06-29 1999-06-29
US60141430 1999-06-29
PCT/US2000/015026 WO2001000674A1 (en) 1999-06-29 2000-06-12 Insulin crystals for pulmonary administration

Publications (1)

Publication Number Publication Date
AU5453300A true AU5453300A (en) 2001-01-31

Family

ID=22495656

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54533/00A Abandoned AU5453300A (en) 1999-06-29 2000-06-12 Insulin crystals for pulmonary administration

Country Status (3)

Country Link
EP (1) EP1196445A1 (en)
AU (1) AU5453300A (en)
WO (1) WO2001000674A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ519403A (en) * 2001-06-21 2005-03-24 Pfizer Prod Inc Use of insulin in a medicament to reduce weight gain in a diabetic patient who is using exogenous insulin to control blood sugar levels
EP1701714A2 (en) 2004-01-07 2006-09-20 Nektar Therapeutics Improved sustained release compositions for pulmonary administration of insulin
DK2254906T3 (en) 2008-03-18 2017-01-23 Novo Nordisk As Protease-stabilized acylated insulin analogues
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9725493B2 (en) * 2013-01-22 2017-08-08 Case Western Reserve University N-terminal truncated insulin analogues
JP6944780B2 (en) * 2014-01-13 2021-10-06 サーマリン インコーポレイテッド Fast-acting insulin preparation and drug delivery system
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
WO2016007682A1 (en) 2014-07-08 2016-01-14 Amphastar Pharmaceuticals Inc. Micronized insulin, micronized insulin analogues, and methods of manufacturing the same
US9892234B2 (en) 2014-10-27 2018-02-13 Aseko, Inc. Subcutaneous outpatient management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
CA2993275C (en) 2015-08-20 2022-06-21 Aseko, Inc. Diabetes management therapy advisor
US10322168B2 (en) * 2016-01-07 2019-06-18 Amphastar Pharmaceuticals, Inc. High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
PE20210857A1 (en) 2016-12-16 2021-05-18 Novo Nordisk As PHARMACEUTICAL COMPOSITIONS CONTAINING INSULIN

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998042368A1 (en) * 1997-03-20 1998-10-01 Novo Nordisk A/S Therapeutic powder formulation for pulmonary administration, containing crystalline insulin
WO1998042367A1 (en) * 1997-03-20 1998-10-01 Novo Nordisk A/S Method for preparation of a therapeutic powder through coprecipitation of insulin and absorption enhancer
US20010007853A1 (en) * 1998-01-08 2001-07-12 Dimarchi Richard Dennis Method for administering monomeric insulin analogs

Also Published As

Publication number Publication date
WO2001000674A1 (en) 2001-01-04
EP1196445A1 (en) 2002-04-17

Similar Documents

Publication Publication Date Title
AU4450700A (en) Insulin crystals for pulmonary administration
AU2955200A (en) Cannula
AU5259100A (en) Medicament
AU1071301A (en) Pharmaceutical compounds
AU7837800A (en) Rapid infusion system
AU6489600A (en) Patient monitor
AU3068599A (en) Medication infusion set
AU2790099A (en) Frame for prone surgical positioning
AU7998900A (en) Automotive-ceiling-mounted monitor
HUP0204109A3 (en) Oral preparations for diabetes
AU2919001A (en) Syringe
AU2440700A (en) Oral arginine and insulin secretion
AU5453300A (en) Insulin crystals for pulmonary administration
AU1453901A (en) Adverse drug event monitoring
AU2225901A (en) Aspartame derivative crystals
AU2544300A (en) Immunogenic compounds
AU3065200A (en) Sleeping bag
AU1303201A (en) Alkoxyiminoalkanoic acid derivatives
AU5722900A (en) Pharmaceutical compounds
AU1541601A (en) Syringes
AU6036100A (en) New pharmaceutically active compounds
AU6480400A (en) Syringe for one-hand use
AU3133400A (en) Syringe
AU2690600A (en) 2-mercaptocarboxylic acid derivatives
AU1752101A (en) Medicament cartridge

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase